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the CC BY-NC-ND license (http://creaAbstract Objectives: To determine changes in the distribution of uropathogens and their
antimicrobial resistance in pediatric patients in a children’s hospital from 2005 to 2016.
Methods: A cross-sectional analysis of uropathogens and their antimicrobial resistance within
inpatient children was performed over the 11-year period, 2005 to 2016, in Ali Asghar chil-
dren’s hospital. The rate of antibiotic resistance among patients was evaluated according to
demographic data including age, sex, urinary tract abnormities and history of antibiotic con-
sumption.
Results: In total, 958 female and 349 male positive cultures were analyzed. Escherichia coli
(77.6%) was the most common causative agent of urinary tract infection (UTI) in children
and Klebsiella pneumoniae (10.4%), Pseudomonas aeruginosa (2.4%), and Enterococcus spp
(2.4%) were less frequent isolated bacteria. The resistance rates of E. coli isolates were
increased against amikacin, ceftriaxone, ceftazidime, ciprofloxacin, cotrimoxazole and imipe-
nem from 2005 to 2010. However, we observed a decreasing trend for some of antibiotics
including amikacin, gentamicin, imipenem, ceftazidime and cotrimoxazole during 2014
e2016. The rate of antibiotic resistance was greater in boys than in girls against many antibi-
otics. The rate of resistance to amikacin, gentamicin, nitrofurantoin and cotrimoxazole in pa-
tients aged <1 year was higher than other age groups (p < 0.001). A higher antibiotic
resistance rate was observed in patients with anatomical abnormality and those who have
had a history of antibiotic consumption.of Microbiology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.
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last 3 years. An effective empirical treatment regime should be based on local epidemiology
and antimicrobial susceptibility testing.
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Urinary tract infections (UTIs) are themost common infection
in the pediatric population, and a common cause of hospi-
talization in infancyandchildhood [1,2].UTIs are significantly
caused byGram-negative bacteria such as Escherichia coli (E.
coli) and Klebsiella pneumoniae (K.pneumoniae), but Gram-
positive pathogens (e.g., Staphylococcus saprophyticus,
Enterococcus faecalis) may also be involved [3e5]. The dis-
ease severity and outcome of UTI can also differ significantly,
and are related to various factors, including gender, age, the
genetic and susceptibility of the host, type of causative or-
ganism, response to antibiotic therapy, the pattern of anti-
biotic resistance, and the clinical management of the patient
[6,7]. Whereas, UTI clinical manifestations in neonate and
children are nonspecific presentations [8]. For this reason, it
should be done promptly urine analysis, culture and antimi-
crobial susceptibility testing on urine specimens that all of
thesecanbeanaid in thediagnosis ofUTI. Furthermore, there
is increasing prevalence of multidrug-resistant (MDR) organ-
isms in pediatric hospitals, with particular concern for
emerging resistance to broad-spectrum cephalosporins and
carbapenems [9,10]. Although international guidelines are
providedempiric treatment recommendations, theseempiric
recommendations should be modified by specialists and mi-
crobiologists in any hospitals for bacterial infections [11].
Since we found no comprehensive study on antimicrobial
resistance in this setting. Awareness and understanding of
local antimicrobial resistance patterns are important for
antibiotic stewardship and initiating empiric antibiotic ther-
apy. In this study, we evaluated the frequency uropathogens
and their susceptibility to tested antibiotics over a 10-year
period as well as effective factors in the incidence of UTI
and antimicrobial resistance in Ali Asghar children’s hospital.
2. Material and methods
2.1. Study design and setting
The study performed at the Ali Asghar children’s hospital,
Tehran, Iran, the pediatric center in the northern end of
Tehran. The source of extracted data was the hospital re-
cords of the patients regarding age, sex, date, method of
urine sample collection, urine culture results, presence of
urinary tract anomalies, previous antibiotic consumption
and antibiogram results. The latter routinely was based on
the report of the laboratory unit of Ali Asghar children’s
hospital which reports antibiogram by a semi-quantitative
approach based on disk diffusion method, and the available
laboratory guidelines.n AR et al., A decade trends of t
ts from Tehran, Iran during 202.2. Inclusion criteria
In the current study, we designed a study population using
simple non-random sampling to recruit all cases with the
diagnosis of UTI admitted to Ali Asghar children’s hospital,
Tehran, Iran in 2005e2016 period. Furthermore, UTI was
defined as: I) A bacterial growth 105 CFU/mL in midstream
urine culture, or 104 CFU/mL from a urine sample ob-
tained by catheterization; II) The presence of greater than
five leukocytes per high-powered field and bacteriuria or a
positive nitrite test or leukocyte esterase. Specimens of
bagged urines were included only if there were two speci-
mens collected with identical results. Only the result of the
first positive urine culture was extracted. In the event of
two separate initial positive cultures, the result of supra-
pubic aspirate was taken into account.
2.3. Exclusion criteria
Those with incomplete records, including the absence of
two confirmatory progress notes regarding urine sample
collection method were excluded from the study. Mixed
growth urine cultures denoting the growth of two or more
organisms in one sample were excluded, as they were likely
to represent contaminated samples. Episodes with urine
samples growing fungal organisms were also excluded.
2.4. Data analysis
All extracted data entered in SPSS (Ver. 22, Armnok, NY, USA)
software spreadsheets. The frequency of uropathogens and
their resistance to the tested antibiotics were compared for
four time periods by using the Chi-square test. In addition,
we analyzed the impact of age, gender, anatomical abnor-
malities and previous antibiotic administration on antibiotic
resistance for a period of 10 years (2005e2016).
3. Results
A total of 1307 non-duplicate urinary isolates were recov-
ered from 958 girls (73.3%) and 349 boys (27.7%) with UTI
during the study period. The biggest percentage of isolates
were from children who have <1 year of age (37.0%), while
the number of isolates were variable among the remaining
age groups (18.8% in patients aged 1e2 years, 6.6% in pa-
tients 2e3 years, 7.1% in patients 3e4 years, 5.7% in pa-
tients 4e5 years, 6.9% in patients 5e6 years and 17.9% in
patients >6 years). The most frequently recovered isolates
were E. coli, 77.6%; K. pneumoniae, 10.7%; Enterococcus
spp, 2.4%; and Pseudomonas aeruginosa, 2.4% (Table 1).he distribution and antimicrobial susceptibility of prevalent uro-
05e2016, Asian Journal of Urology, https://doi.org/10.1016/




Escherichia coli 1014 (77.6)
Klebsiella pneumoniae 140 (10.71)
Pseudomonas aeruginosa 32 (2.44)
Proteus spp 15 (1.14)
Enterobacter spp 13 (1.0)
Acinetobacter spp 3 (0.23)
Other Gram-negative bacteria 8 (0.61)
Gram-positive bacteria
Enterococcus spp 32 (2.44)
Coagulase-negative staphylococci 29 (2.21)
Staphylococcus aureus 5 (0.4)
Other streptococci 14 (1.07)
Other Gram-positive bacteria 2 (0.15)
Total 1307 (100)
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+ MODELFurthermore, among isolates recovered from girls and boys,
the distribution of microorganisms was consistent with the
overall study population. Besides, the resistance rates
against antimicrobial agents are summarized in Table 2 for
Gram-negative and Gram-positive isolated bacteria
respectively. In Gram-negative uropathogens, the rates of
resistance to ampicillin, cotrimoxazole, and oral cephalo-
sporins were very high, and to imipenem, cefepime and
amikacin were lower than others. Vancomycin, nitro-
furantoin and ciprofloxacin were more effective against
Gram-positive bacteria. In addition, the rates of resistance
to amikacin, gentamicin, nitrofurantoin and cotrimoxazole
in patients aged <1 year was higher than other age groupsTable 2 The pattern of antibiotic resistance for selected uropa
Antibiotics Escherichia coli Klebsiella pneumoniae
%R TN %R TN
Amikacin 6.95 950 24.62 130
Gentamicin 19.02 936 29.46 129
Ampicillin 78.75 607 88.68 106
Cefazolin 56.33 529 76.09 100
Cephalexin 52.28 329 57.14 21
Cefuroxime 53.23 387 60 70
Ceftizoxime 29.09 55 33.33 3
Ceftazidime 28.38 613 41.94 93
Cefotaxime 37.75 355 55.56 27
Ceftriaxone 36.08 898 46.28 121
Cefepime 15.58 552 24.72 89
Imipenem 13.16 395 4.55 44
Ciprofloxacin 19.66 829 7.89 114
Ofloxacin 31.11 135 15.38 13
Cotrimoxazole 60.24 835 40.17 117
Nitrofurantoin 2.93 957 17.42 132
Nalidixic acid 46.43 420 18.42 38
Erythromycin e e e e
%R, percentage of resistance, TN, total number;
e, Not performed.
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between aged groups with resistance to other antibiotics.
Table 3 illustrated resistance rates to tested antibiotics,
according to gender during the study period. Also, the rates
of resistance to many antibiotics were greater in boys than
in girls. As shown in Table 4, the changing of resistance was
significant for amikacin, ampicillin, ceftriaxone, ceftazi-
dime, nitrofurantoin and gentamicin during the study
period (2005e2016). Although resistance to ceftriaxone
increased from 30.5% in 2008 to 44.7% in 2013, the resis-
tance rates tended to decrease in 2016. In the next section,
we focused on the effects of anatomical abnormalities on
the distribution of pathogens and their antibiotic resistance
represented in Tables 5 and 6. The frequency of uropath-
ogens including Enterobacter. spp and P. aeruginosa are
higher in patients with anatomical abnormalities in
compared to those without anatomical abnormalities.
We next examined the effects of previous antibiotic
consumption on antimicrobial resistance. For this reason,
patients with anatomical abnormalities such as the neuro-
genic bladder, perineal stenosis, double terminal urethra
were excluded and only 338 patients were included in this
section. More details were representing in Table 7.
4. Discussion
Antimicrobial resistance (AMR) is a serious concern world-
wide and the rising of multidrug resistance strains among
inpatient and outpatient accounting as a potential risk. At
the national level, each country should be promoted
knowledge through surveillance and investigation in the
field of AMR. Throughout the study period, E. coli remained
the most prevalent causative agent of UTI in the pediatric
population, which this finding is consistent with previousthogens.
Pseudomonas aeruginosa Enterococcus spp
%R TN %R TN
6.9 29 71.43 7
24.14 29 85 20
100 14 40.91 22
82.35 17 e e
100 7 e e
92.31 13 e e
e e e e
20.83 24 e e
75.0 12 e e
46.15 26 e e
11.11 18 e e
6.25 16 e e
4 25 60 20
0 4 20 5
81.82 22 73.68 19
83.87 31 16.67 18
76.92 13 42.86 7
e e 76.92 26
he distribution and antimicrobial susceptibility of prevalent uro-
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Table 4 Antimicrobial resistance trends among E.coli isolates from Ali Asghar Hospital, 2005 to 2016.

















Amikacin 9.2% 142 13.6% 213 7.6% 249 1.4% 346 <0.001
Ampicillin 66.7% 6 90% 50 81% 211 75.9% 340 0.058
Ceftriaxone 30.5% 128 42.6% 216 44.7% 215 28.6% 339 <0.001
Ceftazidime 25.8% 62 46.3% 41 40.5% 173 20.5% 337 <0.001
Ciprofloxacin 14.1% 64 21.4% 187 23% 243 17.3% 335 0.027
Cotrimoxazole 65.5% 139 70.8% 192 70.6% 221 42.4% 283 <0.001
Gentamycin 18.4% 136 28.4% 211 24.2% 260 9.1% 329 <0.001
Imipenem 8.3% 36 18.2% 214 10.5% 86 1.7% 59 0.005
Nitrofurantoin 6.7% 134 6% 216 2.3% 263 0.0% 344 <0.001
Table 5 Distribution of UTI etiological agents in patients with and without anatomical abnormalities.
Organisms Patients
with abnormalities,
n (percent of isolates, %)
Patients without
anatomical abnormalities,
n (percent of isolates, %)
Escherichia coli 350 (73.3) 618 (80.7)
Klebsiella pneumoniae 51 (10.6) 79 (10.3)
Pseudomonas aeruginosa 23 (4.8) 7 (0.9)
Enterococcus.spp 11 (2.3) 17 (2.2)
Enterobacter.spp 9 (1.8) 4 (0.5)
Proteus.spp 6 (1.2) 9 (1.2)
Coagulase-negative staphylococci 8 (1.6) 9 (1.2)
Others 19 (3.9) 23 (3)
Table 3 Distribution and frequency of antibiotic resistance uropathogens by gender.









Amikacin 51 (16.8) 303 64 (7.5) 859 <0.001
Ampicillin 169 (83.7) 202 443 (75.9) 584 <0.021
Ceftriaxone 140 (47.5) 295 285 (34.9) 816 <0.001
Ceftazidime 81 (38.9) 208 147 (26.5) 554 <0.001
Nitrofurantoin 47 (14.5) 317 50 (5.6) 891 <0.001
Gentamicin 98 (31.8) 308 160 (18.3) 874 <0.001
Ciprofloxacin 60 (21.5) 279 134 (17.5) 765 <0.142
Imipenem 20 (16.1) 124 38 (10.7) 355 <0.11
Cotrimoxazole 156 (54.4) 287 456 (58.3) 782 <0.247
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+ MODELstudies [2,12e14]. Although E. coli is one of the members of
the intestines microbiota, this organism can result in
various infections, including meningitis, gastroenteritis,
bacteremia and UTI. In the present study, the proportion of
UTI was significantly higher in females (73%) than in males
(27%). Our results were consistent with other studies that
showed that UTI was more frequent in females
[5,13,15,16]. High frequency of UTI in females can be due
to anatomical differences such as shortness of urethra and
close space between the anus and urethral orifice [17,18].
However, some studies reported that UTI at an early age
(<2 years) is greater in boys than girls [19,20]. ThisPlease cite this article as: Nateghian AR et al., A decade trends of t
pathogens among pediatric patients from Tehran, Iran during 20
j.ajur.2020.05.008difference can be due to the lack of circumcision in young
boys. In addition, in our study, the age distribution for UTI
was similar to that of other studies from Iran and other
countries [2,15]. Overall, we found resistance rates of E.
coli to ampicillin, cefazolin, cotrimoxazole, cefuroxime,
and cephalexin were increased during the study period. In
contrast, resistance to ampicillin was 40.9% in Enterococcus
isolates. Similarly, in Taheri and coworker’s study [21], the
resistance rates of E. coli isolates to ampicillin, cefixime,
ceftizoxime, cephalexin, ceftazidime and gentamycin were
93.6%, 85.7%, 78.9%, 77.3%, 53.8% and 59.5%, respectively.
Furthermore, high-frequency resistance to these antibioticshe distribution and antimicrobial susceptibility of prevalent uro-
05e2016, Asian Journal of Urology, https://doi.org/10.1016/
Table 7 Association of among previous antibiotic consumption and antibiotic resistance.
Antibiotics Previous antibiotic consumption (þ) Previous antibiotic consumption () p-Value
Number (%) of resistant isolates Total number Number (%) of resistant isolates Total number
Ampicillin 16 (8.9) 180 6 (4.9) 22 0.192
Amikacin 103 (82.4) 125 66 (68.8) 96 0.017
Cefepime 25 (23.4) 107 5 (5.5) 91 0.0004
Cephalexin 36 (52.9) 68 9 (32.1) 28 0.063
Cefotaxime 31 (43.7) 71 7 (24.1) 29 0.067
Ceftriaxone 73 (42.2) 173 33 (27) 122 0.008
Ceftazidime 34 (31.8) 107 14 (15.4) 91 0.007
Ciprofloxacin 36 (21.1) 171 15 (12.9) 116 0.077
Cotrimoxazole 102 (60.7) 168 43 (41.3) 104 0.002
Gentamicin 40 (20.8) 192 19 (15.4) 123 0.231
Imipenem 10 (11.4) 88 2 (4.3) 47 0.166
Nalidixic acid 41 (49.4) 83 8 (22.9) 35 0.008
Nitrofurantoin 16 (8.3) 193 4 (3.2) 126 0.065
Table 6 Distribution of resistant isolates of E.coli among patients with and without anatomical abnormalities.









Amikacin 57 (8.4) 677 51 (11.9) 426 0.053
Ampicillin 366 (76.2) 480 215 (79.9) 269 0.247
Cefazolin 221 (53.2) 415 157 (72.6) 216 0.0002
Cefepime 65 (15.5) 417 55 (22.1) 248 0.032
Cephalexin 103 (45.7) 225 95 (67.3) 141 0.0005
Ceftriaxone 208 (32.2) 644 196 (47.2) 415 0.0001
Ceftazidime 118 (26.7) 441 101 (35.4) 285 0.0128
Ciprofloxacin 94 (14.9) 627 83 (22.7) 365 0.0021
Cotrimoxazole 361 (57.5) 627 224 (57.5) 389 0.998
Gentamicin 130 (18.5) 699 111 (26.1) 424 0.0027
Imipenem 27 (10.1) 267 28 (15.1) 185 0.108
Nitrofurantoin 45 (6.2) 715 44 (10.1) 434 0.0181
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[2,13,22]. Our findings suggest that ampicillin and oral
cephalosporins should be used as empiric agents only when
potential benefits outweigh risks. According to the results
of the present study the rate of resistance to amikacin,
gentamycin and nitrofurantoin in patients aged <1 year was
higher than other age groups, while resistance to cotri-
moxazole was increasing in aged >1 year. Also, the preva-
lence of resistance between boys was higher than girls to
antibiotics such as amikacin, gentamycin, ceftriaxone,
ceftazidime and nitrofurantoin. However, the impact of
gender and age in increasing antibiotic resistance is a
controversial issue between researchers [23,24]. In addi-
tion, there are several main risk factors including cathe-
terization, use of broad-spectrum antibiotics, acquisition of
multidrug-resistant strains, prolonged hospitalization,
presence of underlying diseases and urinary system disor-
ders that influence UTI incidence and antibiotic resistance.
In the current study, due to insufficient data, we only
evaluated changes of antimicrobial resistance E. coli iso-
lates. During the study period, from 2005 to 2010 resistance
to amikacin, ceftriaxone, ceftazidime, ciprofloxacin,Please cite this article as: Nateghian AR et al., A decade trends of t
pathogens among pediatric patients from Tehran, Iran during 20
j.ajur.2020.05.008cotrimoxazole, imipenem in E. coli isolates were increased.
In a previous study from Spain, the rate of resistance to
third-generation cephalosporins and fluoroquinolones
increased significantly for E. coli infection [25].
The increasing trend of the amikacin, ceftriaxone, cef-
tazidime, ciprofloxacin, cotrimoxazole, imipenem resis-
tance rate for E. coli is consistent with other national
antimicrobial resistance studies [26]. However, we
observed decreasing antimicrobial resistance of E. coli
between 2011 and 2016. Furthermore, resistance to nitro-
furantoin significantly decreased during the study period.
From 2005 to 2010, relative increasing of resistance rates
can be due to various factors such as overuse or inappro-
priate antibiotic therapy for hospital or community-
acquired infections, antimicrobial prophylaxis, poor edu-
cation for combat with antimicrobial resistance, selection
of patients from referral hospital, overuse of antibiotics for
prevention and therapeutic aims in livestock and poultries.
However, we found that the decrease in resistance rates of
E. coli in the last years of the study period. In this context,
the management of antibiotic prescription by physicians,
rising of understanding individuals for antibiotic usage andhe distribution and antimicrobial susceptibility of prevalent uro-
05e2016, Asian Journal of Urology, https://doi.org/10.1016/
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+ MODELpromotion of infection control policies were affected in
decreasing antibiotic resistance. Previous studies were
indicated that various factors including the type of strains,
expression of virulence factors, misuse or overuse of anti-
biotics in human and animal health, anatomical abnormal-
ities may be influence the antimicrobial resistance rates
[27e29]. According to our results, there is an association
between anatomical anomalies, distribution of uropath-
ogens and antibiotic resistance. We found that frequency of
Enterobacter spp and P. aeruginosa were higher in patients
with anatomical abnormities than those without anatomical
abnormities. Furthermore, the study results revealed that
in patients with anatomical anomalies in comparison to
patients without anatomical abnormalities, the resistance
rate increased to cefazoline, cephalexin, cefepime, cef-
tazidime, ceftriaxone, ciprofloxacin, gentamycin and
nitrofurantoin (p < 05) while the rising of resistance was
not significant for amikacin, ampicillin, imipenem and
cotrimoxazole. Ahmed and coworkers [30,31] reported that
the resistance rates to ampicillin and trimethoprim/sulfa-
methoxazole among patients with the genitourinary ab-
normality were more than those without such
abnormalities. In another study conducted in Ontario,
Ottawa, Allen et al. [31] reported that among patients with
genitourinary tract abnormalities, the frequency of resis-
tant E. coli isolates were almost four times more than those
without such abnormalities. The result of this study shows
that the previous history of antibiotic consumption
appeared to be significantly influenced by E. coli resistance
to amikacin, cefepime, ceftazidime, ceftriaxone, nalidixic
acid and cotrimoxazole. In the management of patients
with recurrent infections, vesicoureteral reflux, or other
urological abnormalities, antibiotic prophylaxis is a central
strategy for the prevention of UTI in children. In this
context, Lutter and coworkers [32] reported that the
resistance rate in Enterococci, P. aeruginosa and Klebsiella
oxytoca isolates were increased to cefotaxime among
children receiving prophylactic antibiotics. Also, Olesen
et al. [26] reported that there is high association between
the use of beta-lactams, cephalosporins and trimethoprim/
sulfamethoxazole and quinolones with antibiotic resistance
E. coli isolates. There are several limitations in this study,
including insufficient data for uropathogens other than E.
coli, in some cases, inconsistency the antimicrobial sus-
ceptibility testing with clinical and laboratory standards
institute guidelines, poor laboratory facilities. Further-
more, potential bias is that all of the samples were taken
from patients in a referral hospital.5. Conclusion
During the period of study, we found that E. coli isolates
were the most common etiological agents among other
uropathogens. Also, the prevalence of UTI was affected by
different factors including gender, age, history of antibiotic
exposure, anatomical abnormalities. Furthermore, there
was increasing resistance of E. coli isolates against some of
the broad-spectrum antibiotics or first-line antibiotics be-
tween 2005 and 2010 years. Although the study found a
highly significant association between risk factors UTI and
antimicrobial resistance, it should be noted that many ofPlease cite this article as: Nateghian AR et al., A decade trends of t
pathogens among pediatric patients from Tehran, Iran during 20
j.ajur.2020.05.008complicated patients were referred from other hospital
centers. Additionally, these patients were not the real
representative of community-acquired UTIs, and more in-
vestigations should be performed for estimation of the
resistance rate among common uropathogens. Therefore,
we recommend that physicians should consider the
increased resistance to ampicillin, oral cephalosporins and
cotrimoxazole when they selected an antibiotic empirically
for treatment of pediatric UTI. In this context, it’s impor-
tant that local continuous studies of antimicrobial suscep-
tibility at national and international levels are performed
for the prevention of antimicrobial resistance.
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